| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |